FAKTOR OPTIONSSCHEIN - MERCK & CO. | Market Closed - BOERSE MUENCHEN 14:26:13 2024-06-14 EDT | ||
| 6.38 EUR | +0.20% |
|
| Current month | +10.63% | ||
| 1 month | +0.57% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 24-06-14 | 6.38 | +0.20% |
| 24-06-13 | 6.367 | -1.99% |
| 24-06-12 | 6.496 | -3.19% |
| 24-06-11 | 6.71 | +1.01% |
| 24-06-10 | 6.643 | +1.47% |
Real-time BOERSE MUENCHEN
Last update June 14, 2024 at 02:26 pm
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GK4C9W |
| ISIN | DE000GK4C9W9 |
| Date issued | 2022-04-28 |
| Strike | 86.25 $ |
| Maturity | Unlimited |
| Parity | 6.32 : 1 |
| Emission price | 3 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 7.23 € |
|---|---|
| Lowest since issue | 2.913 € |
| Spread | 0.02 € |
| Spread % | 0.31% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.5
USD
Average target price
142.7
USD
Spread / Average Target
+10.20%
- Stock Market
- Certificates
- Certificat
